feed,title,long_url,short_url
SeekingAlpha,Novartis canakinumab fails another phase 3 study in lung cancer,https://seekingalpha.com/news/3872657,
SeekingAlpha,"Fundamentals, Technicals, & Tactics For An Ugly Market",https://seekingalpha.com/article/4534326,
